Senzar Asset Management

Senzar Asset Management as of Dec. 31, 2015

Portfolio Holdings for Senzar Asset Management

Senzar Asset Management holds 41 positions in its portfolio as reported in the December 2015 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Valeant Pharmaceuticals Int 14.7 $132M 1.3M 101.65
Nevro (NVRO) 12.6 $114M 1.7M 67.51
Teva Pharmaceutical Industries (TEVA) 9.3 $84M 1.3M 65.64
Aetna 6.4 $58M 536k 108.12
Mylan Nv 4.7 $43M 785k 54.07
Allergan 4.3 $39M 125k 312.50
Healthways 3.6 $33M 2.5M 12.87
St. Jude Medical 3.5 $31M 507k 61.77
Concert Pharmaceuticals I equity 3.0 $27M 1.4M 18.97
Biogen Idec (BIIB) 2.9 $26M 86k 306.35
Mallinckrodt Pub 2.4 $22M 292k 74.63
Acorda Therapeutics 2.4 $22M 504k 42.78
Biosante Pharmaceuticals (ANIP) 2.3 $21M 454k 45.12
Retrophin 2.3 $20M 1.1M 19.29
Intra Cellular Therapies (ITCI) 2.1 $19M 353k 53.79
Alder Biopharmaceuticals 2.0 $18M 557k 33.03
Centene Corporation (CNC) 1.9 $17M 260k 65.81
Spectranetics Corporation 1.8 $17M 1.1M 15.06
Universal Health Services (UHS) 1.8 $16M 135k 119.49
Insmed (INSM) 1.4 $13M 689k 18.15
Foamix Pharmaceuticals 1.4 $12M 1.5M 8.11
Tandem Diabetes Care 1.2 $11M 930k 11.81
Syneron Medical Ltd ord 1.2 $11M 1.4M 7.71
Corium Intl 1.2 $11M 1.3M 8.12
Dermira 0.9 $8.6M 248k 34.61
Momenta Pharmaceuticals 0.9 $8.0M 542k 14.84
DaVita (DVA) 0.7 $6.6M 95k 69.71
Select Medical Holdings Corporation (SEM) 0.7 $5.9M 492k 11.91
Five Prime Therapeutics 0.6 $5.6M 136k 41.50
Zogenix 0.6 $5.6M 378k 14.74
Flamel Technologies 0.6 $5.4M 442k 12.21
Enanta Pharmaceuticals (ENTA) 0.6 $5.4M 164k 33.02
Esperion Therapeutics (ESPR) 0.6 $5.0M 224k 22.26
Rigel Pharmaceuticals 0.5 $4.6M 1.5M 3.03
Agile Therapeutics 0.4 $3.8M 387k 9.76
Arena Pharmaceuticals 0.4 $3.7M 1.9M 1.90
Biota Pharmaceuticals 0.4 $3.7M 1.9M 1.94
Inotek Pharmaceuticals 0.4 $3.5M 310k 11.33
Neuroderm Ltd F 0.4 $3.4M 202k 17.05
Sientra 0.4 $3.4M 581k 5.92
Alliqua 0.2 $2.2M 1.0M 2.14